down arrow

Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
788.00
6.05 (0.77%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 14.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 0.28% vs 140.06% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -14.86% vs -63.77% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Novartis India With
Markets Mojo
Figures in Rs cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
335.07
8,558.51
-8,223.44
-96.08%
Other Operating Income
0.00
0.00
0.00
Total Operating income
335.07
8,558.51
-8,223.44
-96.08%
Raw Material Cost
0.00
859.11
-859.11
-100.00%
Purchase of Finished goods
189.98
1,825.86
-1,635.88
-89.60%
(Increase) / Decrease In Stocks
9.86
-60.74
70.60
116.23%
Employee Cost
22.96
1,890.84
-1,867.88
-98.79%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
47.01
1,859.00
-1,811.99
-97.47%
Total Expenditure (Excl Depreciation)
269.81
6,374.07
-6,104.26
-95.77%
Operating Profit (PBDIT) excl Other Income
65.26
2,184.44
-2,119.18
-97.01%
Other Income
61.68
266.64
-204.96
-76.87%
Operating Profit (PBDIT)
126.94
2,451.08
-2,324.14
-94.82%
Interest
1.49
14.57
-13.08
-89.77%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
125.45
2,436.51
-2,311.06
-94.85%
Depreciation
2.61
317.46
-314.85
-99.18%
Profit Before Tax
122.84
2,119.05
-1,996.21
-94.20%
Tax
37.65
399.17
-361.52
-90.57%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
85.19
1,719.88
-1,634.69
-95.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
85.19
1,823.41
-1,738.22
-95.33%
Equity Capital
12.34
40.06
-27.72
-69.20%
Face Value
5.00
1.00
0.00
Reserves
732.48
9,583.75
-8,851.27
-92.36%
Earnings per share (EPS)
34.52
45.52
-11.00
-24.17%
Diluted Earnings per share
34.50
45.45
-10.95
-24.09%
Operating Profit Margin (Excl OI)
19.48%
25.52%
0.00
-6.04%
Gross Profit Margin
37.44%
28.47%
0.00
8.97%
PAT Margin
25.42%
20.10%
0.00
5.32%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 335.07 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit 85.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.26 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 0.28% vs 140.06% in Mar 2023

Annual - Interest
Interest 1.49 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -14.86% vs -63.77% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.48%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023